Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebound airway hyper-responsiveness after levosalbutamol vs racemic salbutamol in persistent asthma
2007-005160-27Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Levosalbutamol, Racemic salbutamol and Placebo (3 arms). Primary endpoints: Bronchoprotection to methacholine after first dose and Bronchoprotection to methacholine after chronic dosing. Started Dec 2007; status: completed.
02
Drugs
levalbuterolsalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-005160-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005160-27.